|
Akshay Nadkarni is involved in multiple activities across the firm ranging from in-depth technology analysis to assisting in M&A and the corporate valuation process. He is focused on grasping the key value drivers of international life science companies in order to identify creative strategic opportunities for various international clients. As part of the M&A team, Akshay has undertaken extensive research and has assisted in cross-border transactions involving companies in several emerging biotech fields, including molecular imaging, biogenerics, and advanced immunotherapy. In addition, he has written several industry profiles and company reports involving emerging companies in various sectors of biotechnology. Akshay holds a Bachelor of Arts in Biology and Finance from New York University. | 